Biomedical Pioneering Innovation Center (BIOPIC), and School of Life Sciences, Peking University, Beijing, 100871, China.
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center (SYSUCC), Guangzhou, Guangdong, 510060, China.
Cell Res. 2020 Nov;30(11):950-965. doi: 10.1038/s41422-020-00402-8. Epub 2020 Sep 8.
Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated malignancy with a complex tumor ecosystem. How the interplay between tumor cells, EBV, and the microenvironment contributes to NPC progression and immune evasion remains unclear. Here we performed single-cell RNA sequencing on ~104,000 cells from 19 EBV NPCs and 7 nonmalignant nasopharyngeal biopsies, simultaneously profiling the transcriptomes of malignant cells, EBV, stromal and immune cells. Overall, we identified global upregulation of interferon responses in the multicellular ecosystem of NPC. Notably, an epithelial-immune dual feature of malignant cells was discovered and associated with poor prognosis. Functional experiments revealed that tumor cells with this dual feature exhibited a higher capacity for tumorigenesis. Further characterization of the cellular components of the tumor microenvironment (TME) and their interactions with tumor cells revealed that the dual feature of tumor cells was positively correlated with the expression of co-inhibitory receptors on CD8 tumor-infiltrating T cells. In addition, tumor cells with the dual feature were found to repress IFN-γ production by T cells, demonstrating their capacity for immune suppression. Our results provide new insights into the multicellular ecosystem of NPC and offer important clinical implications.
鼻咽癌(NPC)是一种与 EBV 相关的恶性肿瘤,具有复杂的肿瘤生态系统。肿瘤细胞、EBV 和微环境之间的相互作用如何促进 NPC 的进展和免疫逃逸仍不清楚。在这里,我们对来自 19 个 EBV NPC 和 7 个非恶性鼻咽活检的约 104000 个细胞进行了单细胞 RNA 测序,同时对恶性细胞、EBV、基质和免疫细胞的转录组进行了分析。总的来说,我们在 NPC 的多细胞生态系统中发现了干扰素反应的全局上调。值得注意的是,发现了恶性细胞的上皮-免疫双重特征,并与不良预后相关。功能实验表明,具有这种双重特征的肿瘤细胞具有更高的致瘤能力。进一步对肿瘤微环境(TME)的细胞成分及其与肿瘤细胞的相互作用进行了特征分析,发现肿瘤细胞的双重特征与 CD8 肿瘤浸润 T 细胞上共抑制受体的表达呈正相关。此外,还发现具有双重特征的肿瘤细胞能够抑制 T 细胞产生 IFN-γ,表明其具有免疫抑制能力。我们的研究结果为 NPC 的多细胞生态系统提供了新的见解,并为临床提供了重要的意义。